(Total Views: 139)
Posted On: 07/10/2023 10:45:49 AM
Post# of 24

$EXAI News Article - GT Apeiron Announces Enrollment of First Patient in Phase 1/2 "ELUCIDATE" Clinical Trial of CDK7 Inhibitor, GTAEXS617, in Advanced Solid Tumors https://marketwirenews.com/news-releases/gt-a...29221.html


My Twitter: WhyteStocks